A team of researchers will present findings at the Alzheimer’s Association International Conference 2013 from a clinical trial testing an experimental drug, called CHF5074, in people with early memory problems.
A team of scientists at Boston University Medical School have performed a genetic study to try to unravel whether there is a genetic basis to why Alzheimer’s progresses faster in some people than others.
Scientists in Italy have studied patient records of more than 200,000 people and revealed that those with Alzheimer’s have a lower risk of cancer and vice versa.
Birmingham City University researchers have worked together with colleagues in China to study structural changes in the brains of people with early memory and thinking problems, detecting distinct changes in those at high risk of Alzheimer’s disease.
New research from the US has linked activities such as reading and writing to a slower rate of cognitive decline in old age.
US scientists have found that a new molecule, called MW108, may hold potential as a treatment for Alzheimer’s disease.